Statins as Repurposed Anticancer Agents: Regulated Cell Death, the Tumor Immune Microenvironment, and the Translational Evidence Gap

Xu Zhou, Yizhang Chen, Hanxiao Hua, Bo Shen, Shuai Liang, Dong Hua

Open source

DOI
10.1002/ddr.70388
Published
2026-09-20
Container
Drug Development Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ddr.70388,
  title = {Statins as Repurposed Anticancer Agents: Regulated Cell Death, the Tumor Immune Microenvironment, and the Translational Evidence Gap},
  author = {Xu Zhou and Yizhang Chen and Hanxiao Hua and Bo Shen and Shuai Liang and Dong Hua},
  year = {2026},
  journal = {Drug Development Research},
  doi = {10.1002/ddr.70388},
  url = {https://doi.org/10.1002/ddr.70388}
}

RIS

TY  - JOUR
TI  - Statins as Repurposed Anticancer Agents: Regulated Cell Death, the Tumor Immune Microenvironment, and the Translational Evidence Gap
AU  - Xu Zhou
AU  - Yizhang Chen
AU  - Hanxiao Hua
AU  - Bo Shen
AU  - Shuai Liang
AU  - Dong Hua
PY  - 2026
JO  - Drug Development Research
DO  - 10.1002/ddr.70388
UR  - https://doi.org/10.1002/ddr.70388
ER  - 

APA

Zhou, X., Chen, Y., Hua, H., Shen, B., Liang, S., & Hua, D. (2026). Statins as Repurposed Anticancer Agents: Regulated Cell Death, the Tumor Immune Microenvironment, and the Translational Evidence Gap. Drug Development Research. https://doi.org/10.1002/ddr.70388

Source records